Effects of allopurinol on endothelial dysfunction: A meta-analysis

dc.contributor.authorKanbay, Mehmet
dc.contributor.authorSiriopol, Dimitrie
dc.contributor.authorNistor, Ionut
dc.contributor.authorElcioglu, Omer C.
dc.contributor.authorTelci, Ozge
dc.contributor.authorTakır, Mümtaz
dc.contributor.authorJohnson, Richard J.
dc.date.accessioned2025-05-10T15:24:06Z
dc.date.issued2014
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective: Several studies have assessed the effect of allopurinol on endothelial function, but these studies were relatively small in size and used different methods of evaluating endothelial function. We conducted a meta-analysis to investigate the effect of allopurinol on both endothelial-dependent and -independent vasodilatation. Methods: Electronic databases, Medline, PubMed, EMBASE, SCOPUS, EBSCO and the Cochrane Library Central Register of Clinical Trials were searched from January 1985 to July 2013 on clinical trials (randomized and non-randomized) which assessed the effect of allopurinol on endothelial function. We conducted a sensitivity analysis to assess the contribution of each study to the pooled treatment effect by excluding each study one at a time and recalculating the pooled treatment effect for the remaining studies. Treatment effect was significant if p < 0.05. We assessed for heterogeneity in treatment estimates using the Cochran Q test and the ?2 statistic (with substantial heterogeneity defined as values >50%). Results: The final analysis consisted of 11 studies (2 observational and 9 randomized). For the endothelial-dependent vasodilatation there were 6 studies, including 257 patients, that evaluated flow-mediated dilatation and 5 studies with 87 patients that reported data on forearm blood flow response to acetylcholine or flow-dependent vasodilatation. Overall, there was a significant increase in the endothelium-dependent vasodilatation with allopurinol treatment (MD 2.69%, 95% CI 2.49, 2.89%, p < 0.001; heterogeneity ?2 = 319.1, I2 = 96%, p < 0.001). There was only 1 study (100 patients) assessing nitrate-mediated dilatation and 4 studies (73 patients) evaluating forearm blood flow response to sodium nitroprusside as measures of endothelial-independent vasodilatation. The overall analysis (MD -0.08, 95% CI -0.50, 0.34, p = 0.70; heterogeneity ?2 = 9.0, I2 = 44%, p = 0.11) showed no effect of allopurinol treatment on endothelium-independent vasodilatation. Conclusions: We found that treatment of hyperuricemia with allopurinol is associated with an improvement in the endothelial-dependent, but not with the endothelial-independent vasodilatation. © 2014 S. Karger AG, Basel.
dc.identifier.doi10.1159/000360609
dc.identifier.endpage356
dc.identifier.issn0250-8095
dc.identifier.issue4
dc.identifier.pmid24751886
dc.identifier.scopus2-s2.0-84898675778
dc.identifier.scopusqualityQ1
dc.identifier.startpage348
dc.identifier.urihttps://doi.org/10.1159/000360609
dc.identifier.urihttps://hdl.handle.net/20.500.14730/6637
dc.identifier.volume39
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherS. Karger AG
dc.relation.ispartofAmerican Journal of Nephrology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20250302
dc.subjectAllopurinol; Cardiovascular disease; Endothelial dysfunction; Uric acid
dc.titleEffects of allopurinol on endothelial dysfunction: A meta-analysis
dc.typeReview

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
6637.pdf
Boyut:
175.57 KB
Biçim:
Adobe Portable Document Format